Pharma-Biotech Needs a New Financing Model or We Are Doomed!
Duane Roth, CEO, CONNECT Webinar Date: April 27, 2011 Agenda: \u00bb What killed the fully integrated model? \u00bb Has the start-up model run its course? \u00bb What will the next model look like? \u00bb Where will future investments come from? \u00bb What role should federal and state government play? Speaker Biography: Duane J. Roth is Chief Executive Officer and Member of the Board of CONNECT. CONNECT is the globally recognized nonprofit organization dedicated to creating and sustaining the growth of innovative technology and life science businesses in San Diego. CONNECT has been directly involved with over 2000 companies since its inception in 1985 and these companies have secured over $10 billion in funding. Prior to joining CONNECT, Mr. Roth founded Alliance Pharmaceutical Corp., where he served as Chairman of the Board. Prior to Alliance, he held senior management positions at Johnson Johnson and Wyeth (now Pfizer) operating companies. He has served as a Member of the Board of Directors and executive committees of the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI) and BIOCOM (past Chair). Mr. Roth was appointed to the oversight board of the California Institute of Regenerative Medicine (CIRM) by Governor Arnold Schwarzenegger in 2006 and was elected Vice Chairman in 2009.From:ShareVaultViews:0 0ratingsTime:53:57More inEducation<\/p>\n
Originally posted here: Pharma-Biotech Needs a New Financing Model or We Are Doomed! Duane Roth, CEO, CONNECT Webinar Date: April 27, 2011 Agenda: \u00bb What killed the fully integrated model? \u00bb Has the start-up model run its course? \u00bb What will the next model look like? Continue reading
\nPharma-Biotech Needs a New Financing Model or We Are Doomed! - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"